Impact Biomedical (IBO) Assets (2022 - 2026)
Impact Biomedical (IBO) recorded Assets of $16.43 million in Q3 2026, down 9.8% from $18.21 million a year earlier and down 1.9% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Impact Biomedical reported Assets of $17.41 million, down 14.2% from FY2024.
- Annual Assets has declined for three straight years, with a three-year compound annual growth rate of -27.9% (FY2022 to FY2025).
- Across earlier years, Assets came in at $20.29 million in FY2024 (-54.5%), $44.63 million in FY2023 (-4.0%) and $46.5 million in FY2022.
- The Q3 2026 figure is the lowest quarterly Assets in data going back to Q4 2022.
- On a year-over-year basis, Assets has declined for eight consecutive quarters, with an average decline of 34.8% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 3.6% in Q3 2024, against a decline of 61.0% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.75 million (Q2 2026), $17.09 million (Q1 2026) and $17.41 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 16.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.43 Mn |
| Jun 30, 2026 | 16.75 Mn |
| Mar 31, 2026 | 17.09 Mn |
| Dec 31, 2025 | 17.41 Mn |
| Sep 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 19.06 Mn |
| Mar 31, 2025 | 20.05 Mn |
| Dec 31, 2024 | 20.29 Mn |
| Sep 30, 2024 | 46.70 Mn |
| Jun 30, 2024 | 44.12 Mn |
| Mar 31, 2024 | 44.36 Mn |
| Dec 31, 2023 | 44.63 Mn |
| Sep 30, 2023 | 45.08 Mn |
| Jun 30, 2023 | 45.99 Mn |
| Dec 31, 2022 | 46.50 Mn |
API Access
Impact Biomedical Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();